Atlas Trials

The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma

Clinical trial NCT04020705 · COMPLETED

Trial details

NCT number
NCT04020705
Sponsor
Istituto di Ricerca Neuroftalmologia S.r.l.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Glaucoma
Start date
2015-09-22
Primary completion
2019-03-19
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.